EUVIMEDEUVIMED entdecken
Crossref

Inhibition of AhR disrupts intestinal epithelial barrier and induces intestinal injury by activating NF ‐ κB in COPD

Liuying Tao iD, Qin Zhang iD, Lan Liu iD, Kun Wang iD, Juanhui Wang iD, Xuefang Liu iD, Peng Zhao iD, Jiansheng Li iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202402320r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Liuying Tao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Receptors, Aryl Hydrocarbon, NF-kappa B, Intestinal Mucosa. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: The National Key Research and Development Program of China, The Joint Fund for Science and Technology Research of Henan Province, Key Scientific Research Project of Colleges and Universities in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) is frequently associated with intestinal comorbidities. Damage to the intestinal barrier plays a crucial role in these disorders, leading to increased intestinal and systemic inflammation, and thereby promoting the progression of COPD. This study aims to investigate the mechanism of intestinal epithelial barrier damage, focusing on the roles of the Aryl hydrocarbon Receptor (AhR) and NF‐κB in COPD‐related intestinal damage. A COPD rat model was induced by cigarette smoke and bacterial infection, while Caco‐2/HT29 intestinal epithelial cells were treated with TNF‐α or IL‐1β to assess intestinal disorder and the underlying mechanisms of barrier damage. COPD rats exhibited significant lung function decline, pathological damage, and inflammatory response in lung tissues. Additionally, significant intestinal injury was observed, accompanied by pronounced colonic pathological damage, an enhanced inflammatory response, and intestinal barrier disruption. This was evidenced by decreased expression of apical junction proteins and elevated serum diamine oxidase levels. Pro‐inflammatory cytokines TNF‐α or IL‐1β significantly downregulated the expression of apical junction proteins in Caco‐2/HT29 cells, reduced transepithelial electrical resistance of Caco‐2 cells, and increased FD‐4 permeability. Moreover, TNF‐α or IL‐1β induction activated NF‐κB in Caco‐2/HT29 cells, with a similar activation observed in the colonic tissues of COPD rats. The NF‐κB inhibitor PDTC suppressed this activation and protected against intestinal epithelial barrier damage. Furthermore, AhR inhibition was observed both in vitro and in vivo. The AhR activator FICZ inhibited NF‐κB activation and mitigated intestinal epithelial barrier damage, whereas the AhR inhibitor CH223191 inhibited AhR and exacerbated intestinal epithelial barrier damage by facilitating NF‐κB activation. However, the NF‐κB inhibitor PDTC did not significantly affect AhR. Additionally, TNF‐α/IL‐1β inhibited the binding of AhR and p‐NF‐κB. Consequently, AhR inhibition can downregulate the expression of apical junction proteins, probably through activation of NF‐κB signaling leading to intestinal epithelial barrier damage. This study confirmed the presence of lesions in the lungs and intestines of COPD rats, as well as the associated damage to the intestinal epithelial barrier. The inhibition of AhR followed by the activation of NF‐κB has been identified as a critical mechanism underlying the injury to the intestinal epithelial barrier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveReceptors, Aryl HydrocarbonNF-kappa BIntestinal MucosaAnimalsHumansRatsMaleCaco-2 CellsRats, Sprague-DawleyHT29 CellsTumor Necrosis Factor-alphaSignal TransductionInterleukin-1betaBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

AhRNF‐κBchronic obstructive pulmonary diseaseintestinal epithelial barrier

Substanzen

Receptors, Aryl HydrocarbonNF-kappa BTumor Necrosis Factor-alphaInterleukin-1betaBasic Helix-Loop-Helix ProteinsAhr protein, rat

Autor:innen und Institutionen

  • Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, Zhengzhou, Henan, China.
  • Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan province & Education Ministry of P.R. China, Zhengzhou, Henan, China.
  • Department of Respiratory Diseases, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China.
  • Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, Henan, China.

ORCID-Profile: Liuying Tao, Qin Zhang, Lan Liu, Kun Wang, Juanhui Wang, Xuefang Liu, Peng Zhao, Jiansheng Li

Förderung

  • The National Key Research and Development Program of China
  • The Joint Fund for Science and Technology Research of Henan Province
  • Key Scientific Research Project of Colleges and Universities in Henan Province
  • the Training Program for Young Core Faculty in Undergraduate Universities in Henan Province
  • the Henan University Science and Technology Innovation Talent Support Program
  • the Zhengzhou Science and Technology Collaborative Innovation Project

Zitieren

APA

Tao, L., Zhang, Q., Liu, L., Wang, K., Wang, J., Liu, X., Zhao, P., & Li, J. (2024). Inhibition of AhR disrupts intestinal epithelial barrier and induces intestinal injury by activating NF ‐ κB in COPD. The FASEB Journal. https://doi.org/10.1096/fj.202402320r

Vancouver

Tao L, Zhang Q, Liu L, Wang K, Wang J, Liu X, et al. Inhibition of AhR disrupts intestinal epithelial barrier and induces intestinal injury by activating NF ‐ κB in COPD. The FASEB Journal. 2024. doi:10.1096/fj.202402320r

BibTeX
@article{Tao2024,
  author = {Tao, Liuying and Zhang, Qin and Liu, Lan and Wang, Kun and Wang, Juanhui and Liu, Xuefang and Zhao, Peng and Li, Jiansheng},
  title = {Inhibition of AhR disrupts intestinal epithelial barrier and induces intestinal injury by activating NF ‐ κB in COPD},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202402320r}
}
Kostenlos starten →